SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-14-047769
Filing Date
2014-02-12
Accepted
2014-02-12 14:26:02
Documents
1
Group Members
BIOTECH TARGET N.V.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G d674849dsc13ga.htm SC 13G/A 49242
  Complete submission text file 0001193125-14-047769.txt   50928
Mailing Address VORDERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8200
Business Address VORDERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8200 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Subject) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-78830 | Film No.: 14599374
SIC: 2836 Biological Products, (No Diagnostic Substances)